… to treat patients with acute steroid-resistant ulcerative colitis since the beginning of 1991. Of
the 55 patients so far elected for treatment, … of steroid-unresponsive ulcerative colitis. As the …

… biologic treatments and regimens for ulcerative colitis in … the treatment algorithm for
moderateto-severe ulcerative colitis but … Until recently, the efficiency of genetic editing was …

… These findings indicate that an efficient treat-to-target strategy combining clinical symptoms
and UC non-invasive specific biomarkers of inflammation (such as FC) may be superior to …

… inflammatory bowel disease ie, ulcerative colitis will be examined. … ulcerative colitis is
examined in experimental animal models. To compare the efficiency of the nanoparticles treatment, …

… loaded with a very low dose of siRNA-CD98 reduced the expression of CD98, implicated in
ulcerative colitis, in the ileum and colon, and thus may be useful for treating ulcerative colitis. …

… ulcerative colitis have a severe attack requiring hospitalization at some time during their
illness. This treatment … Mortality in severe episodes of ulcerative colitis decreased from 31–61% …

… to obtain data on the efficiency of the biologic treatments of UC. … studied: ulcerative colitis,
ulcerative disease, colitis ulcerosa. … was searched using the term ‘ulcerative colitis’. In the CRD …

… Hence, different biological agents that target specific immunological pathways are being
investigated for treating ulcerative colitis. Anti-tumor necrosis factor (TNF) agents were the first …

Oral nanoparticles have been considered a prospective drug delivery carrier against ulcerative
colitis (UC). To enhance the mucus-penetrating capacity and aqueous solubility, and …

… Crohn’s disease (CD) and ulcerative colitis (UC) are the 2 major types of IBD. CD affects
the … , we found that these GDNPs targeted the colon efficiently and were absorbed mainly by …